Award GB CF

Multi-Drug Resistant TB (MDR-TB) Clinical Advice Service

NHS England

Stage: Award

the latest stage the buyer has published
Buyer: NHS England
Supplier: British Thoracic Society

named in the award notice
Value: £88K

net · GBP
Awarded: 28 Jun 2023

the award date on the notice
End date: 31 Mar 2025

expected
First published: 12 Jan 2024

last seen 12 Jan 2024

What the buyer published

The MDR-TB Clinical Advice Service provides expert, consistent and safe advice to clinicians treating MDR-TB. The Clinical Advice Service examines and ratifies local MDR-TB centre requests for the use of the MDR-TB agents, Bedaquiline and Delamanid.

View the original notice ↗

History of this contract

An empty stage is useful. For example, no tender stage usually means the buyer used a framework or gave the contract directly.

◌ Planning none

◌ Tender none

● Award on record

● End date 31 Mar 2025, expected

Why this is not a cyber contract

Judged against the rules we publish. How we decide.